Indigenous Products Warning Letter Details

Summary

Based on limited metadata available, Indigenous Products received an FDA Warning Letter on December 10, 2020 regarding drug products under FDA jurisdiction. Without access to the complete warning letter text or subject line, the specific nature of the violations cannot be determined from the metadata provided. The letter was issued by the FDA's drug regulatory program, though the specific issuing office is not identified in the available information. To understand the particular compliance concerns and required corrective actions, review of the full warning letter would be necessary.